Mmastodon WorldWorld first seen 7 h ago, last 2 min ago, peak #1

Imaavy approved as first treatment for warm autoimmune hemolytic anemia

Original: Recently, Imaavy (nipocalimab-aahu) becomes the first approved treatment for warm autoimmune hemolytic anemia (wAIHA). A

Imaavy (nipocalimab-aahu) has become the first approved treatment for warm autoimmune hemolytic anemia, a rare condition in which the immune system destroys the body's own red blood cells. The approval is being welcomed as a significant step for orphan drug development, offering patients with a previously untreatable disease a targeted option.

Why now: The drug's approval marks the first-ever treatment for a rare disease that previously had none, which is notable medical news.

Imaavynipocalimab-aahuwarm autoimmune hemolytic anemia

Open on mastodon →

Rank over time, top of the chart is #1. 8 snapshots from 7 h ago to 2 min ago.

Evidence

• Recently, Imaavy (nipocalimab-aahu) becomes the first approved treatment for warm autoimmune hemolytic anemia (wAIHA). Another win to tackle orphan diseases. https://www. reactiondigest.com/Biochemistr y/Drug-target/Imaavy # chemistry # pharmaceuticals # news # biotech #… · eronsaxon · 4

API: https://socialmediatrends-api.osmike.com/v1/trends/955074